- Release Date: 16/03/21 10:16
- Summary: DEP HER2-lutetium outperforms in human breast cancer model
- Price Sensitive: Yes
- Download Document 252.17KB
- Forums
- ASX - By Stock
- SPL
- Ann: DEP HER2-lutetium outperforms in human breast cancer model
Ann: DEP HER2-lutetium outperforms in human breast cancer model
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.81M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 40638 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 49656 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.094 |
3 | 580559 | 0.093 |
1 | 10331 | 0.090 |
2 | 41247 | 0.089 |
2 | 116000 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.093 | 49656 | 2 |
0.095 | 2000 | 1 |
0.096 | 100000 | 1 |
0.097 | 50309 | 2 |
0.098 | 200000 | 1 |
Last trade - 10.07am 12/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
Day chart unavailable